A STUDY OF THE INTERACTION OF ROXITHROMYCIN WITH THEOPHYLLINE AND CARBAMAZEPINE

被引：37

作者：

SAINTSALVI, B ^{[1
]}

TREMBLAY, D ^{[1
]}

SURJUS, A ^{[1
]}

LEFEBVRE, MA ^{[1
]}

机构：

[1] CEPHAC POITIERS,POITIERS,FRANCE

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1987年 / 20卷

关键词：

D O I：

10.1093/jac/20.suppl_B.121

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：121 / 129

页数：9

共 25 条

[1]

ALBIN H, 1982, THERAPIE, V37, P151

[2] CLINICAL PHARMACOKINETICS OF CARBAMAZEPINE [J].

BERTILSSON, L .

CLINICAL PHARMACOKINETICS, 1978, 3 (02) :128-143

[3] THE EFFECTS OF ERYTHROMYCIN ON THE ABSORPTION AND DISPOSITION KINETICS OF THEOPHYLLINE [J].

BRANIGAN, TA ;

ROBBINS, RA ;

CADY, WJ ;

NICKOLS, JG ;

UEDA, CT .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :115-120

[4]

BRAZIER JL, 1980, THERAPIE, V35, P545

[5] THEOPHYLLINE REASSESSED [J].

BUKOWSKYJ, M ;

NAKATSU, K ;

MUNT, PW .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) :63-73

[6] PLASMA KINETICS OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN MAN AFTER SINGLE AND MULTIPLE DOSES [J].

EICHELBAUM, M ;

EKBOM, K ;

BERTILSSON, L ;

RINGBERGER, VA ;

RANE, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :337-341

[7] LACK OF CLINICALLY IMPORTANT INTERACTION BETWEEN ERYTHROMYCIN AND THEOPHYLLINE [J].

HILDEBRANDT, R ;

GUNDERTREMY, U ;

MOLLER, H ;

WEBER, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (04) :485-489

[8]

ILIOPOULOU A, 1982, BRIT J CLIN PHARM, V14, P445

[9] PHARMACOKINETIC DRUG-INTERACTIONS WITH THEOPHYLLINE [J].

JONKMAN, JHG ;

UPTON, RA .

CLINICAL PHARMACOKINETICS, 1984, 9 (04) :309-334

[10]

KURISU S, 1984, DRUG INTEL CLIN PHAR, V18, P390

← 1 2 3 →